This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Machado, R. D. Articles by Aldred, M. A. Search for Related Content PubMed PubMed Citation Articles by Machado, R. D. Articles by Aldred, M. A. Related Collections Other hypertension Pulmonary biology and circulation Pulmonary circulation and disease Other Vascular biology Related Article

(Circulation. 2005;111:607-613.)
© 2005 American Heart Association, Inc.

Hypertension

Investigation of Second Genetic Hits at the BMPR2 Locus as a Modulator of Disease Progression in Familial Pulmonary Arterial Hypertension

Rajiv D. Machado, PhD^*; Victoria James, BSc^*; Mark Southwood, BSc; Rachel E. Harrison, MRCPCH; Carl Atkinson, PhD; Susan Stewart, FRCPath; Nicholas W. Morrell, MD; Richard C. Trembath, FRCP; Micheala A. Aldred, DipRCPath

From the Division of Medical Genetics (R.D.M., V.J., R.E.H., R.C.T., M.A.A.), Departments of Genetics and Cardiovascular Sciences, University of Leicester, Leicester, UK; and the Division of Respiratory Medicine (M.S., C.A., S.S., N.W.M.), Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrookes and Papworth Hospitals, Cambridge, UK.

Correspondence to Richard C. Trembath, Professor of Medical Genetics, Departments of Genetics and Cardiovascular Sciences, Adrian Bldg, University of Leicester, University Road, Leicester, LE1 7RH, UK. E-mail rtrembat{at}hgmp.mrc.ac.uk

Received August 25, 2004; revision received September 24, 2004; accepted October 5, 2004.

Background— Primary pulmonary arterial hypertension (PAH) is a potentially devastating condition resulting from occlusion of the pulmonary arterioles by the formation of vascular lesions. Heterozygous mutations in the gene encoding the bone morphogenetic protein receptor type II (BMPR2) have been identified in both familial (FPAH) and idiopathic PAH. Mutant alleles are typically of low penetrance, indicating that other factors are required for the onset of PAH. Previous reports have suggested that the characteristic plexiform lesions in affected lungs are akin to neoplasia, showing monoclonal expansion and microsatellite instability. We hypothesized that in patients with germline mutations, BMPR2 might behave as a classic tumor suppressor gene, with somatic loss of the wild-type allele contributing to disease progression.

Methods and Results— To test this hypothesis, plexiform and concentric vascular lesions were serially microdissected from lung explant tissue derived from 7 FPAH cases. DNA was analyzed for loss of heterozygosity at BMPR2 and for microsatellite instability (MSI) at 5 loci. MSI was detected in 1 of 37 lesions at a single locus, BAT-26, whereas heterozygosity at BMPR2 was retained at all informative loci. We also describe a FPAH patient carrying biallelic constitutional missense mutations of BMPR2 who manifested disease at a stage and manner similar to heterozygous patients.

Conclusions— Taken together, these data demonstrate that MSI is uncommon in FPAH and suggest that somatic loss of the remaining wild-type BMPR2 allele in heterozygous mutation carriers likely does not play a significant role in modulating the onset or progression of FPAH.

Key Words: hypertension, pulmonary • genetics • lung • genes • pathology

Related Article:

Pathogenesis of Pulmonary Arterial Hypertension: The Need for Multiple Hits

Jason X.-J. Yuan and Lewis J. Rubin
Circulation 2005 111: 534-538. [Extract] [Full Text]

This article has been cited by other articles:

				K.-H. Hong, Y. J. Lee, E. Lee, S. O. Park, C. Han, H. Beppu, E. Li, M. K. Raizada, K. D. Bloch, and S. P. Oh Genetic Ablation of the Bmpr2 Gene in Pulmonary Endothelium Is Sufficient to Predispose to Pulmonary Arterial Hypertension Circulation, August 12, 2008; 118(7): 722 - 730. [Abstract] [Full Text] [PDF]

				B. Sztrymf, F. Coulet, B. Girerd, A. Yaici, X. Jais, O. Sitbon, D. Montani, R. Souza, G. Simonneau, F. Soubrier, et al. Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 Mutation Am. J. Respir. Crit. Care Med., June 15, 2008; 177(12): 1377 - 1383. [Abstract] [Full Text] [PDF]

				National Pulmonary Hypertension Centres of the UK Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland Heart, March 1, 2008; 94(Suppl_1): i1 - i41. [Full Text] [PDF]

				National Pulmonary Hypertension Centres of the UK Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland Thorax, March 1, 2008; 63(Suppl_2): ii1 - ii41. [Full Text] [PDF]

				P. B. Sehgal and S. Mukhopadhyay Dysfunctional Intracellular Trafficking in the Pathobiology of Pulmonary Arterial Hypertension Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 31 - 37. [Abstract] [Full Text] [PDF]

				P. B. Sehgal and S. Mukhopadhyay Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs? Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H77 - H85. [Abstract] [Full Text] [PDF]

				P. B. Sehgal, S. Mukhopadhyay, F. Xu, K. Patel, and M. Shah Dysfunction of Golgi tethers, SNAREs, and SNAPs in monocrotaline-induced pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1526 - L1542. [Abstract] [Full Text] [PDF]

				S. I. Said, S. A. Hamidi, K. G. Dickman, A. M. Szema, S. Lyubsky, R. Z. Lin, Y.-P. Jiang, J. J. Chen, J. A. Waschek, and S. Kort Moderate Pulmonary Arterial Hypertension in Male Mice Lacking the Vasoactive Intestinal Peptide Gene Circulation, March 13, 2007; 115(10): 1260 - 1268. [Abstract] [Full Text] [PDF]

				N. W. Morrell Pulmonary Hypertension Due to BMPR2 Mutation: A New Paradigm for Tissue Remodeling? Proceedings of the ATS, November 1, 2006; 3(8): 680 - 686. [Abstract] [Full Text] [PDF]

				S. I. Said Mediators and modulators of pulmonary arterial hypertension Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L547 - L558. [Abstract] [Full Text] [PDF]

				V. V. McLaughlin and M. D. McGoon Pulmonary Arterial Hypertension Circulation, September 26, 2006; 114(13): 1417 - 1431. [Full Text] [PDF]

				K. A. Young, C. Ivester, J. West, M. Carr, and D. M. Rodman BMP signaling controls PASMC KV channel expression in vitro and in vivo Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L841 - L848. [Abstract] [Full Text] [PDF]

				K. Teichert-Kuliszewska, M. J.B. Kutryk, M. A. Kuliszewski, G. Karoubi, D. W. Courtman, L. Zucco, J. Granton, and D. J. Stewart Bone Morphogenetic Protein Receptor-2 Signaling Promotes Pulmonary Arterial Endothelial Cell Survival: Implications for Loss-of-Function Mutations in the Pathogenesis of Pulmonary Hypertension Circ. Res., February 3, 2006; 98(2): 209 - 217. [Abstract] [Full Text] [PDF]

				J. X.-J. Yuan and L. J. Rubin Pathogenesis of Pulmonary Arterial Hypertension: The Need for Multiple Hits Circulation, February 8, 2005; 111(5): 534 - 538. [Full Text] [PDF]